AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16391217
Drug: L-arginine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (3 g 3 times a day for 6 months)
Trial: 10806282
Drug: lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lovastatin (20 mg)
Trial: 29894467
Drug: Masseter muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Masseter muscle injection with type A botulinum toxin
Trial: 29894467
Drug: No masseter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No masseter muscle injection with type A botulinum toxin (Control)
Trial: 21624491
Drug: AZD1236 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1236 75 mg, twice daily for 6 weeks
Trial: 17487212
Drug: Low-fat (20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat (20% of energy), high-fiber (18 g per 1000 kcals of energy intake), high-fruit and -vegetable (5-8 servings per day) dietary intervention
Trial: 12955427
Drug: 1-month clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-month clopidogrel therapy (75 mg p.o. for 1 month)
Trial: 12955427
Drug: 6-month clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month clopidogrel therapy (75 mg p.o. for 6 months)
Trial: 3896657
Drug: Piretanide (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide (6 mg) once daily
Trial: 3896657
Drug: Furosemide (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (40 mg) once daily
Trial: 3896657
Drug: Piretanide (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide (6 mg) twice daily at 08.00 and 20.00 hours
Trial: 3896657
Drug: Piretanide (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide (6 mg) twice daily at 08.00 and 12.00 hours or 08.00 and 20.00 hours
Trial: 30555463
Drug: Novel vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel vaccine approaches for malaria
Trial: 17922666
Drug: TNF antagonists
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: TNF antagonists
Trial: 11936912
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg/day for 3 days; n = 133)
Trial: 10325453
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg donepezil
Trial: 10325453
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg donepezil
Trial: 8545142
Drug: Controlled-release (CR)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (CR) codeine (mean daily dose: 273 ± 78 mg, range: 200-400 mg)
Trial: 8594122
Drug: Controlled-release (CR)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (CR) codeine
Trial: 1426661
Drug: Ribomunyl treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribomunyl treatment (4 days) with amoxicillin
Trial: 20560941
Drug: Vaginal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal and sublingual routes
Trial: 12098721
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 500 IU daily for four years
Trial: 30251369
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg/d (n=1,467)
Trial: 23326213
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein lycosome formulation (WPL)
Trial: 23326213
Drug: Control groups
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control groups (lycopene, WP singular formulation, placebo)
Trial: 19385712
Drug: Duloxetine 20-60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 20-60 mg/day orally, once or twice daily (up to 120 mg/day)
Trial: 15310635
Drug: Low-dose IT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose IT lidocaine (15 mg) and sufentanil (10 microg)
Trial: 15310635
Drug: IT lidocaine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT lidocaine (50 mg)
Trial: 25268878
Drug: Curcuminoids (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuminoids (500 mg TID per oral)
Trial: 23778938
Drug: Intanza/IDflu (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intanza/IDflu (9 µg for 18-59 y, 15 µg for ≥ 60 y)
Trial: 23778938
Drug: Trivalent intramuscular
RxNorm normalized name: Afluria, trivalent intramuscular suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent intramuscular vaccine (Vaxigrip(®) 15 µg)
Trial: 19336629
Drug: Rapid maxillary
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid maxillary expansion (RME) in addition to fixed appliance therapy
Trial: 9247755
Drug: ACE inhibitor-based
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor-based treatment
Trial: 8100928
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg rhDNase twice daily for 10 days
Trial: 3493794
Drug: Methohexitone 2
RxNorm normalized name: Methohexitone
DrugBank: Methohexital (DB00474)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methohexitone 2 mg kg‐1
Trial: 24597465
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg TG hydrochloride
Trial: 24597465
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg TG hydrochloride
Trial: 24597465
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg TG hydrochloride
Trial: 24597465
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg TG hydrochloride (multiple doses every 12h for 5 days)
Trial: 18956276
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (initially 25 microg, followed by 50 microg and 100 microg every 4 hours)
Trial: 18956276
Drug: Vaginal dinoprostone
RxNorm normalized name: dinoprostone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal dinoprostone (3 mg every 6 hours)
Trial: 15654934
Drug: Olanzapine treatment
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine treatment for 27.9±20.1 weeks
Trial: 10651074
Drug: Interferon-alpha2a (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha2a (3 million units subcutaneously, twice a week for 3 months)
Trial: 1845847
Drug: Cisplatin 100
RxNorm normalized name: CISPLATIN 100MG/VIL (PF) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 100 mg/m2 IV day 1 and etoposide 120 mg/m2 IV days 1, 2, and 3
Trial: 1845847
Drug: Cisplatin 100
RxNorm normalized name: CISPLATIN 100MG/VIL (PF) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 100 mg/m2 IV day 1 and etoposide 120 mg/m2 IV day 1 and 240 mg/m2 orally days 2 and 3
Trial: 6353336
Drug: Cefazoline (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazoline (500 mg intramuscular every 8 hours for 6 doses)
Trial: 6353336
Drug: Cotrimoxazole (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotrimoxazole (800 mg sulfametoxazole and 160 mg trimetoprime intramuscular every 12 hours for 6 doses)
Trial: 30777064
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (MT) and stabilizing exercises (SEs)
Trial: 11912561
Drug: Psyllium (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (15 g PSY/d)
Trial: 8880382
Drug: Intramuscular and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular and intralesional beta-interferon treatment
Trial: 8880382
Drug: Intramuscular beta-interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular beta-interferon treatment
Trial: 8880382
Drug: Intralesional beta-interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional beta-interferon treatment
Trial: 2114628
Drug: Almitrin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrin (75 mg acute administration)
Trial: 2114628
Drug: Almitrin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrin (3 x 25 mg for 6 months)
Trial: 2114628
Drug: Almitrin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrin (75 mg additional administration)
Trial: 31097067
Drug: Drug-resistant tuberculosis
RxNorm normalized name: Mycobacterium tuberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-resistant tuberculosis (DR-TB) patients
Trial: 28103819
Drug: Telbivudine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telbivudine (600 mg/day)
Trial: 28103819
Drug: Entecavir (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entecavir (0.5 mg/day)
Trial: 26016867
Drug: Krill and
RxNorm normalized name: Schiff Antarctic Krill and Fish Oil Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill and salmon oil (KS oil), 5 1-g capsules for 8 weeks
Trial: 26016867
Drug: Control (canola
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (canola oil), 5 1-g capsules for 8 weeks
Trial: 23287748
Drug: Standard fluoroscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fluoroscopic assistance (OEC 9900; G.E. HealthCare)
Trial: 19363873
Drug: Topical retinoids
RxNorm normalized name: tocopheryl retinoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical retinoids (e.g., adapalene, tazarotene)
Trial: 19363873
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (topical retinoids with benzoyl peroxide and/or antibiotics and/or hormonal therapy)
Trial: 19363873
Drug: Topical retinoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical retinoid monotherapy
Trial: 19363873
Drug: Fixed-combination products
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-combination products (topical retinoid/antimicrobial therapy)
Trial: 11562516
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid supplementation (500 mg twice daily) for 2 weeks
Trial: 7821003
Drug: Potassium dichromate
RxNorm normalized name: Potassium dichromate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium dichromate (2.5 mg)
Trial: 3133250
Drug: hFSH (human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hFSH (human follicle-stimulating hormone)
Trial: 30942033
Drug: Thumb-tack acupuncture
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thumb-tack acupuncture with surrounding needling method plus medication (oral valaciclovir hydrochloride, mecobalamin, vitamin B1)
Trial: 30942033
Drug: Medication alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication alone (oral valaciclovir hydrochloride, mecobalamin, vitamin B1)
Trial: 30942033
Drug: Thumb-tack acupuncture
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thumb-tack acupuncture with surrounding needling method plus medication
Trial: 10757255
Drug: Venlafaxine (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (titrated to a maximum of 150 mg/day)
Trial: 10757255
Drug: Amitriptyline (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (titrated to a maximum of 150 mg/day)
Trial: 1419551
Drug: Ofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (200 mg od)
Trial: 1419551
Drug: Trimethoprim (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (200 mg bd)
Trial: 1419551
Drug: Co-trimoxazole (trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (trimethoprim 160 mg and sulphamethoxazole 800 mg bd)
Trial: 6362695
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine (2 and 3 ml)
Trial: 6362695
Drug: 0.5% amethocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% amethocaine (2 and 3 ml)
Trial: 20486336
Drug: PureZone, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PureZone, a combination therapy involving localized air filtration and pillow encasement
Trial: 11574360
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg ketamine
Trial: 7939487
Drug: Supportive psychotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive psychotherapy (in combination with benzodiazepines)
Trial: 3148941
Drug: 150 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 micrograms selenium per oral administration after two hours of hard training
Trial: 30507604
Drug: Organ dose
RxNorm normalized name: argan oil
DrugBank: Argan oil (DB14310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organ dose modulation with ASiR-V algorithm
Trial: 28737262
Drug: 7% hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7% hypertonic saline (HS) inhaled for 8 hours overnight using the tPAD system
Trial: 28737262
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (nasal cannula without aerosol)
Trial: 28737262
Drug: 7% hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7% hypertonic saline (HS) inhaled
Trial: 25310142
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBT and pharmacotherapy
Trial: 16837882
Drug: letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: letrozole 2.5 mg/day
Trial: 16837882
Drug: placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo tablet
Trial: 10857519
Drug: Resistive inspiratory
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistive inspiratory muscle training (RIMT) for 15 to 20 minutes per session, twice per day, 7 days a week for 6 weeks.
Trial: 9663827
Drug: Bismuth carbomer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth carbomer foam enemas (270 mg elemental bismuth)
Trial: 20132529
Drug: Buspirone (10‐15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (10‐15 mg/day)
Trial: 17132920
Drug: Serum alpha-fetoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum alpha-fetoprotein (AFP) > or = 20 ng/mL
Trial: 17132920
Drug: Serum alpha-fetoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum alpha-fetoprotein (AFP) > or = 100 ng/mL
Trial: 17132920
Drug: Serum alpha-fetoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum alpha-fetoprotein (AFP) > or = 100 ng/mL with AST <= 2 ULN
Trial: 17132920
Drug: Serum alpha-fetoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum alpha-fetoprotein (AFP) > or = 100 ng/mL with AST > 2 ULN
Trial: 17132920
Drug: Serum alpha-fetoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum alpha-fetoprotein (AFP) > or = 200 ng/mL with AST > 2 ULN
Trial: 10791619
Drug: Oxaceprol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxaceprol (400 mg t.i.d.)
Trial: 9348578
Drug: UFT (tegafur
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (tegafur and uracil) 400 mg/day for 1 year after surgery
Trial: 3548984
Drug: Diflunisal (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diflunisal (500 to 750 mg/day, twice daily)
Trial: 3548984
Drug: Ibuprofen (1,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (1,600 to 2,400 mg/day, four times daily)
Trial: 29311084
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg relebactam with 500 mg imipenem-cilastatin, given intravenously every 6 h for 5 doses
Trial: 22610770
Drug: Fluency-enhancing therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluency-enhancing therapy
Trial: 16171667
Drug: Clonidine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (single intravenous dose; 4 microg/kg for patients ≤65 years, 3 microg/kg for patients >65 years)
Trial: 12855343
Drug: Capsaicin 50
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin 50 microg/ml (0.25, 0.5, 0.75, 1.0, 1.5, 2.0, and 3 ml)
Trial: 12855343
Drug: Glycerol (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol (2.5, 5, and 10 ml)
Trial: 12855343
Drug: Saline (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (2.5, 5, and 10 ml)
Trial: 9095707
Drug: Atracurium 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.05 mg/kg followed by succinylcholine 1.5 mg/kg
Trial: 1683981
Drug: Saline (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (80 ml)
Trial: 1683981
Drug: No peritoneal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No peritoneal administration
Trial: 31952131
Drug: Three dates
RxNorm normalized name: Date
DrugBank: Date (DB10632)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three dates daily for 16 weeks
Trial: 27142792
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg + Ezetimibe 10 mg
Trial: 12056673
Drug: Cinnarizine 15
RxNorm normalized name: cinnarizine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnarizine 15 mg
Trial: 12056673
Drug: Cinnarizine 30
RxNorm normalized name: cinnarizine
DrugBank: Cinnarizine (DB00568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnarizine 30 mg
Trial: 12056673
Drug: Cinnarizine 45
RxNorm normalized name: cinnarizine
DrugBank: Cinnarizine (DB00568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinnarizine 45 mg
Trial: 12056673
Drug: Promethazine 10
RxNorm normalized name: promethazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine 10 mg (active control)
Trial: 6461679
Drug: Isotretinoin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin (1 mg/kg)
Trial: 6461679
Drug: Etretinate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etretinate (1 mg/kg)
Trial: 9066317
Drug: Intrathecal sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal sufentanil (10 micrograms) plus bupivacaine (2.5 mg) plus epinephrine (0.2 mg)
Trial: 9066317
Drug: Intrathecal sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal sufentanil (10 micrograms) plus bupivacaine (2.5 mg) plus normal saline (control)
Trial: 20433999
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin nadroparin
Trial: 19229379
Drug: Oral ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ketoprofen (300 mg)
Trial: 19229379
Drug: Oral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paracetamol (4 g)
Trial: 1832372
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (2 mg)
Trial: 1832372
Drug: Aerosol pentamidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol pentamidine (60 mg)
Trial: 463806
Drug: Natural orange
RxNorm normalized name: Dex4 Natural Orange
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural orange juice (80 mg of ascorbic acid daily)
Trial: 463806
Drug: Synthetic orange
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic orange juice (80 mg of ascorbic acid daily)
Trial: 23450052
Drug: PCOS women
RxNorm normalized name: Arthricare for Women Moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCOS women with lower insulin sensitivity index (Si)
Trial: 16642421
Drug: Protected alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Protected alendronate 70 mg/day
Trial: 16642421
Drug: Standard alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard alendronate 70 mg/day
Trial: 10073783
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day of quinapril
Trial: 6160322
Drug: Metoprolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (10 mg IV)
Trial: 6160322
Drug: Propranolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (10 mg IV)
Trial: 18797697
Drug: Rosuvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (10 mg a day, orally)
Trial: 15736995
Drug: Nine-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nine-valent pneumococcal conjugate vaccine